Scientific Advisory Board (SAB)

President of the External Scientific Committee

He graduated from the University of Genoa School of Medicine in 1959. He specialised in hematology in Pavia and at the University of Columbia, New York. He was the Scientific Director at the Tumour Institute of Tuscany (Florence) and Professor of Hematology at the University of Florence.

He was the founder of the Hematology and Blood Transfusion Society of Nigeria, of which he has been honorary member since 1968. Amongst other posts Dr. Luzzato was Director of the International Genetics and Biophysics Institute at the National Research Centre (CNR) in Naples (1974-1981). He was also the Director of the Hematology Department at Hammersmith Hospital in London (1981-1994) and President of the Human Genetics Department at Cornell University, New York (1994-2004). From 2000 until 2006 he was the Scientific Director at the National Cancer Research Institute in Genoa. Since 2006 he has been the Director of the Instituti Toscani de Tumori in Florence. He is currently developing his scientific work in Tanzania. 

Member of the External Scientific Committee

He graduated summa cum laude in Medicine from Harvard Medical School where he also qualified as a Doctor in 1985. He was Internal Medicine Resident at the University of Miami (Jackson Memorial Hospital) where he also served his Postdoctoral Fellowship.

He is currently Professor at the Department of Dermatology and Medicine at Harvard Medical School and Director of the Program of Excellence in Glycosciences. Prof. Sackstein is a international specialist in bone marrow transplantation and its complications as graft versus host disease.

Prof. Sackstein is also a hematologist at the Dana-Farber Cancer Institute; Director of the Translational Research Program and Bone Marrow Transplant Service at Massachusetts General Hospital, and member of the International Scientific Committee of the Josep Carreras Leukaemia Foundation from 2016. Prof. Sackstein has been actively involved in the development of the Institute since its inception.

Member of the External Scientific Committee

He holds a degree in Medicine from the University of Salamanca and from the New University of Lisbon. He obtained the title of Doctor in 1987 from the University of Salamanca. Currently he is Titular Professor and Director of the General Cytometry Service of this university.

His activities are focused on research in the clinical area and, above all, in the field of the immune system and cancer, about which he has contributed more than 100 articles to international
publications over the last five years.

Amongst other posts Prof. Orfao was president of the Iberian Cytometry Society (1995-1999) and he was president of the International Federation of Clinical Chemistry Clinical Flow Cytometry Standardisation Committee (1994-1997). At the present time he is a member of the European Group for the Characterisation of Leukaemia. At the present time he is Professor of the Department of Medicine of the University of Salamanca, Member of the European Leukaemia Characterization Group and Scientific Director of the National DNA Bank of the Carlos III Health Institute.

Member of the External Scientific Committee

He qualified as a doctor in 1981 from the University of Pisa. He specialised in hematology at the University of La Sapienza in Rome. Amongst other posts Prof. Lococo was President of the Italian Experimental Hematology Society (2000-2002). He was also a member of the Ministry of Hematological Health Research Committee (SIE), a member of the Board of the Italian Cancer Research Foundation (AIRC) and a member of the Italian Health Ministry Research Committee (2001-2002).

He is currently Professor of Hematology and he is the director of the Laboratory of Integrated Diagnosis of Oncohematologic Diseases at the Department of Biopathology at the University of Rome Tor Vergata. He is also President of the GIMEMA Italian National Cooperative Group’s APL Subcommittee, President of the GIMEMA AML Biology Subcommittee, President of the European Hematology Association (EHA) Education Committee, and member of the editorial board of the journals Leukemia, Journal of Clinical Oncology and Haematology.

Member of the External Scientific Committee

She studied medicine at Ludwig-Maximilian University in Munich and at Kiel University. She was the deputy-director of the of Kiel University Human Genetics Institute. Her research and studies have taken Prof. Schlegelberger to the Karolinska Institute in Stockholm, the University of Chicago, the Memorial Sloan Kettering Cancer Center in New York, the British Columbia Cancer Center of Vancouver and the St. Jude Children's Research Hospital in Memphis, United States.

Her studies have focused on the identification of recurrent chromosome alterations in leukaemia and malignant lymphomas. In 2001 she was appointed Director of the Hannover School of Medicine Cellular and Molecular Pathology Institute, Germany. The Institute has, in collaboration with many study groups, integrated the cytogenetic and molecular analysis of pilot clinical studies into myelodysplastic syndromes and leukaemia in children and adults.

At the present time, she is Professor and Director of Hannover Medical School Genetics Institute.